National Drug Code (NDC) Database
CARBOGEN AMCIS B.V.
-
NDC:
45408-002
-
Nonproprietary Name:
CALCIFEDIOL
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
CALCIFEDIOL ANHYDROUS
-
Start Marketing Date:
2012-08-31
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Cardinal Health 414, LLC
-
NDC:
65857-800
-
Nonproprietary Name:
Gallium Chloride GA-68
-
Dosage Form:
SOLUTION
-
Product Type:
BULK INGREDIENT
-
Strength:
400 mCi/mL
-
Substance:
GALLIUM CHLORIDE GA-68
-
Start Marketing Date:
2024-04-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
CATALENT ARGENTINA S.A.I.C.
-
NDC:
49588-0005
-
Nonproprietary Name:
Ibuprofen
-
Dosage Form:
CAPSULE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
200 mg/1
-
Substance:
IBUPROFEN
-
Start Marketing Date:
2025-06-27
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Catalent Argentina S.A.I.y.C
-
NDC:
49588-0001
-
Nonproprietary Name:
Ibuprofen
-
Dosage Form:
CAPSULE, LIQUID FILLED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
200 mg/1
-
Substance:
IBUPROFEN
-
Start Marketing Date:
1995-04-10
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Catalent Germany Schorndorf GmbH
-
NDC:
68621-0062
-
Nonproprietary Name:
dutasteride and tamsulosin hydrochloride
-
Dosage Form:
CAPSULE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
.5; .4 mg/1; mg/1
-
Substance:
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
-
Start Marketing Date:
2024-06-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Catalent Indiana, LLC
-
NDC:
61434-077
-
Nonproprietary Name:
Aflibercept
-
Dosage Form:
INJECTION, SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
114.3 mg/mL
-
Substance:
AFLIBERCEPT
-
Start Marketing Date:
2025-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Catalent Micron Technologies Limited
-
NDC:
69989-0006
-
Nonproprietary Name:
Apixaban
-
Dosage Form:
POWDER
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1 kg/1
-
Substance:
APIXABAN
-
Start Marketing Date:
2016-05-11
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Catalent Micron Technologies Ltd
-
NDC:
69989-0013
-
Nonproprietary Name:
Rimegepant
-
Dosage Form:
POWDER
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1 kg/1
-
Substance:
RIMEGEPANT
-
Start Marketing Date:
2020-10-06
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Catalent Micron Technologies, Inc.
-
NDC:
69988-0065
-
Nonproprietary Name:
Gentamicin Sulfate
-
Dosage Form:
POWDER
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1 kg/1
-
Substance:
GENTAMICIN SULFATE
-
Start Marketing Date:
2025-02-28
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
-
NDC:
69507-001
-
Nonproprietary Name:
DEXTROSE MONOHYDRATE
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
DEXTROSE MONOHYDRATE
-
Start Marketing Date:
2015-01-09
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.